Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$403K of BMY shares in the open market
Traded Sep 9, 2026 · Filed Sep 10, 2026
- ~$403K
- Reported value · 6,249 sh @ $64.57
- 19K
- Holds after · shares reported
- -4.6%
- stock since the trade · S&P 500 +0.2%, $64.41 → $61.46 on Oct 1
Why it stands out
Bristol Myers Squibb's Chief Med Offr,Head of Dev sold $403K of Bristol Myers Squibb shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 10, 2026
Officer$100K–$500K
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$403,498
Shares × reported transaction price
- Timing vs results
41 days after results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Price at the time
Closed at $64.41 on Sep 9, 2026, 51% above its 52-week low and 5% below its high, after a 1% rise over the previous 30 trading days
